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Mahler and colleagues posed a question on the reliability of the indirect immunofluorescence method using the HEp-2 cell line in their recent Arthritis Research and Therapy article [1] . Products from three different companies showed different staining patterns on the same anti-ribosomal P (antiRib-P) in the pictures they revealed. In addition to the antiRib-P that Mahler and colleagues mentioned, limitations of the HEp-2 cell line in the detection of autoantibodies such as anti-Ro have long been pointed out. The HEp-2000 cell line, which was developed to overcome such limitations, did not show any superior performance in the detection of anti-Rib-P since it was a form of HEp-2 cell that was transfected with cDNA encoding human Ro60. A human macrophage cell line called the IT-1 cell line was first introduced at the American College of Rheumatology meeting held in Minneapolis in 1994 [2] , the same time as HEp-2000 was presented. IT-1 had been commercialized and passed inspection by the Korea Food and Drug Administration in South Korea. Currently, IT-1 is being used under the name of the autoimmune target (AIT) test and it participates in the quality control program run by the Korean Society of Laboratory Medicine [3] . In 1999 and 2007, reports of antinuclear antibody test using the IT-1 cell line on 208 and 588 systemic lupus erythematosus (SLE) patients, respectively, showed a 100% positive rate that proved an exceptional improvement in the test performance [4, 5] . Furthermore, the AIT test can indirectly help in the diagnosis of SLE using the microtubule organizing center pattern (MTOC) that can only be observed in the IT-1 cell line [4] .
We investigated patients who were tested for anti-Rib-P using a double immunodiffusion method from April 1995 to March 2009. Anti-Rib-P was detected in 102 patients. AIT tests showed all positive results in anti-Rib-P-positive patients, and all patients showed a diffuse cytoplasmic pattern with no exception (Table 1) . Although there were some differences according to other accompanying fluorescent patterns, most of the patients (100 patients, 98%) showed a high titer of greater than 1:640 (Table 1) .
Opinions about including anti-Rib-P in the diagnostic criteria of SLE have been recently suggested, like Mahler and Letter AIT test has no problem in the detection of anti-ribosomal P Table 1 Immunofluorescence patterns and titers of the autoimmune target test in anti-ribosomal P-positive patients AIT = autoimmune target; anti-Rib-P = anti-ribosomal P; SLE = systemic lupus erythematosus.
